FibroGen Inc. 8-K Report Insights - February 2025 Filing

Based on the provided XML data from the financial report, here are the key points extracted:

1. Entity Information:

• Company Name: FibroGen Inc.
• CIK (Central Index Key): 0000921299
• IRS Employer Identification Number: 77-0357827

2. Document Details:

• Filing Type: 8-K (Current Report)
• Filing Date: February 24, 2025
• SEC File Number: 001-36740

3. Stock Information:

• Common Stock Par Value: $0.01
• Ticker Symbol: FGEN
• Exchange: NASDAQ

4. Contact Information:

• Address: 350 Bay Street, Suite 100 #6009, San Francisco, CA 94133
• Phone Number: 415-978-1200

5. Period of Reporting:

• Report Period: The report covers the date of February 24, 2025.

Insights:

• The filing type (8-K) indicates that this report may contain significant events that shareholders should be aware of, such as acquisitions, changes in management, or other important corporate developments.
• The date of the report suggests it is a current event filing, meaning the information is timely and could affect the stock's performance.
• Being listed on NASDAQ under the ticker symbol FGEN, investors can track the stock's performance easily, and the par value of $0.01 indicates it is a low-value common stock typically associated with smaller companies or startups.
  
  This section does not provide detailed financial data or specific events, so further analysis of the actual filings or additional sections may be necessary for comprehensive insights.